Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

ZIOPHARM Oncology COO Richard Bagley Steps Down

Biopharmaceutical company ZIOPHARM Oncology, Inc. (ZIOP: Quote) said Monday that the company's President, Chief Operating Officer and Director Richard Bagley is leaving the company and stepping down from the company's board of Directors.

The company also noted that Mark Thornton, Executive Vice President, Government Affairs, Health Policy and Advocacy and Chief Quality Compliance Officer, is also leaving ZIOPHARM to pursue other opportunities.

The company said that the President of Research and Development and Chief Medical Officer, Hagop Youssoufian, will assume the additional responsibility of oversight of all regulatory affairs and clinical operations. Also Caesar Belbel, Executive Vice President, Chief Legal Officer and Secretary, will shoulder the additional responsibility for corporate and business development.

The company also noted that Jason Amello, Executive Vice President and Chief Financial Officer, will continue to be responsible for finance and information technology, and Lynn Ferrucci, Senior Vice President, Human Resources, will continue to oversee human resources.

Register
To receive FREE breaking news email alerts for ZIOPHARM Oncology Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.